Prices delayed by at least 15 minutes | Print
Puretech Health PLC (PRTC)
ORD 1PThis share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Regular investment and Dividend reinvestment
Company profile
PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, whichderives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.
Address
6 St Andrew Street
5th Floor
London
GBR
EC4A 3AE
Forecast key dates
| Name | Key Date |
|---|---|
| PureTech Health PLC Annual General Meeting for 2026 | 2026-06-16T11:00:00 |
| PureTech Health PLC Fourth Quarter Earnings Conference Call for 2025 | 2026-04-30T14:00:00 |
| PureTech Health PLC Fourth Quarter Earnings Results for 2025 | 2026-04-30T00:00:00 |
| PureTech Health PLC Annual Report for 2025 | 2026-04-30T00:00:00 |
| PureTech Health PLC Second Quarter Earnings Conference Call for 2025 | 2025-08-28T09:00:00 |
| PureTech Health PLC Second Quarter Earnings Results for 2025 | 2025-08-28T00:00:00 |
| PureTech Health PLC Annual General Meeting for 2025 | 2025-06-16T11:00:00 |
| PureTech to Present at the Jefferies Global Healthcare Conference | 2025-06-05T10:30:00 |
Previous key dates
| Name | Key Date |
|---|---|
| PureTech Health PLC Annual General Meeting for 2025 | 2025-06-16T11:00:00 |
| PureTech to Present at the Jefferies Global Healthcare Conference | 2025-06-05T10:30:00 |
| PureTech Health PLC Fourth Quarter Earnings Conference Call for 2024 | 2025-04-30T14:00:00 |
| PureTech Health PLC Fourth Quarter Earnings Result for 2024 | 2025-04-30T00:00:00 |
| PureTech Health PLC Annual Report for 2024 | 2025-04-30T00:00:00 |
| Leerink Partners Global Healthcare Conference | 2025-03-11T13:00:00 |
| 43rd Annual J.P. Morgan Healthcare Conference | 2025-01-15T14:15:00 |
| ELEVATE IPF Phase 2b Trial | 2024-12-16T09:00:00 |
| Jefferies London Healthcare Conference | 2024-11-19T14:30:00 |
| UBS Global Healthcare Conference | 2024-11-13T08:45:00 |
| PureTech Health PLC Second Quarter Earnings Conference Call for 2024 | 2024-08-28T09:00:00 |
| PureTech Health PLC Second Quarter Earnings Result for 2024 | 2024-08-28T00:00:00 |
| PureTech Health PLC Annual General Meeting for 2024 | 2024-06-13T11:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2025 AJ Bell. All rights reserved.